Teladoc (TDOC) & Concord Medical Services (CCM) Head to Head Contrast

Teladoc (NYSE: TDOC) and Concord Medical Services (NYSE:CCM) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, profitability, risk, earnings, institutional ownership, analyst recommendations and dividends.

Insider & Institutional Ownership

How to Become a New Pot Stock Millionaire

1.8% of Concord Medical Services shares are held by institutional investors. 4.5% of Teladoc shares are held by insiders. Comparatively, 46.5% of Concord Medical Services shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.



Valuation and Earnings

This table compares Teladoc and Concord Medical Services’ gross revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Teladoc $233.28 million 11.31 -$106.78 million ($1.65) -25.91
Concord Medical Services $65.54 million 2.22 -$37.71 million ($0.87) -3.86

Concord Medical Services has lower revenue, but higher earnings than Teladoc. Teladoc is trading at a lower price-to-earnings ratio than Concord Medical Services, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Teladoc and Concord Medical Services’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Teladoc -45.77% -20.95% -13.11%
Concord Medical Services N/A N/A N/A

Volatility and Risk

Teladoc has a beta of 0.36, indicating that its share price is 64% less volatile than the S&P 500. Comparatively, Concord Medical Services has a beta of 0.73, indicating that its share price is 27% less volatile than the S&P 500.

Analyst Recommendations

This is a summary of recent ratings and target prices for Teladoc and Concord Medical Services, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Teladoc 0 4 12 0 2.75
Concord Medical Services 0 0 0 0 N/A

Teladoc presently has a consensus price target of $41.93, indicating a potential downside of 1.92%. Given Teladoc’s higher possible upside, analysts clearly believe Teladoc is more favorable than Concord Medical Services.

Summary

Concord Medical Services beats Teladoc on 9 of the 13 factors compared between the two stocks.

Teladoc Company Profile

Teladoc, Inc. provides telehealth services worldwide. It offers a portfolio of services and solutions covering 450 medical subspecialties, such as flu and upper respiratory infections, cancer, and congestive heart failure. The company provides its services through mobile devices, the Internet, video, and phone. It serves employers of Fortune 1000 companies, health plans, health systems, and other entities. Teladoc, Inc. was founded in 2002 and is headquartered in Purchase, New York.

Concord Medical Services Company Profile

Concord Medical Services Holdings Limited, through its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the People's Republic of China. The company's services comprise linear accelerators external beam radiotherapy, gamma knife radiosurgery, head gamma knife systems, body gamma knife systems, CyberKnife robotic radiosurgery system, proton beam therapy systems, and diagnostic imaging services. It also offers other treatments and diagnostic services through the use of medical equipment comprising electroencephalography for the diagnosis of epilepsy; thermotherapy for pain relief after radiotherapy and chemotherapy; ultrasound therapy for the treatment of cancer; stereotactic radiofrequency ablation for the treatment of Parkinson's disease; and refraction and tonometry for the diagnosis of ophthalmic conditions, as well as CT scanners and ECT scanners for diagnostic imaging. In addition, the company provides clinical support services, including developing treatment protocols for doctors; and organizing joint diagnosis between doctors in its network and clinical research. Further, it offers radiotherapy and diagnostic equipment leasing and management services to hospitals, as well as consulting services; sells medical equipment; and researches and develops medical technology. Additionally, the company establishes the Beijing Proton Medical Center that provides radiotherapy treatment options to cancer patients; and other specialty cancer hospitals, which offer radiotherapy services, diagnostic imaging services, chemotherapy, and surgery. As of December 31, 2016, it operated a network of 95 cooperative centers based in 57 hospitals in 49 cities across 19 provinces and administrative regions in China. Concord Medical Services Holdings Limited was incorporated in 2007 and is headquartered in Beijing, the People's Republic of China.

Receive News & Ratings for Teladoc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply